Kristen Ambrose Sells $376K of Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Feb 27, 2024
Open-Market Net Sale · SEC Form 4
−$375,893
10b5-1 Plan
Equity position changed by -17.7%
Equity Position
7.97K sh
9,676 → 7,965
Equity Change
-17.7%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Vertex Pharmaceuticals Inc MA
VRTX
CIK 0000875320
All Vertex Pharmaceuticals Inc MA insider activity
Reporting Owner
| Name | Relationship |
|---|---|
| Kristen Ambrose CIK 0001856587 |
CAO
|
Kristen Ambrose at Vertex Pharmaceuticals Inc MA
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$1,978,865
More from this insider at Vertex Pharmaceuticals Inc MA
| 2026-09-01 | Award | — | View |
| 2026-03-02 | Sell | -$172,560 | View |
| 2026-02-26 | Sell | -$108,456 | View |
| 2026-02-19 | Sell | -$1,064,297 | View |
| 2026-02-18 | - | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2024-02-23 | F - Tax Payment 10b5-1 | 828 D | $431.79 | -$357,522 | 8,848 | Direct |
| Common StockF1 | 2024-02-26 | S - Sale 10b5-1 | 883 D | $425.70 | -$375,893 | 7,965 | Direct |
Footnotes (1)
- F1
- Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023. Show more
Related filings at Vertex Pharmaceuticals Inc MA
Institutional Holders
13F holders · Jun 30, 2026
1,768
institutional managers reporting a position
Largest by reported value
- Capital World Investors $13B
- Black Rock, Inc. $12B
- Capital Research Global Investors $9.68B
5%+ Holders · 13D/G
3 filers
Other insiders at Vertex Pharmaceuticals Inc MA
GET /v1/forms/4/0000875320-24-000097
API docs
View Original SEC Filing